Latest News

The Giordani Group is delighted to announce that Prof. Silvia Giordani (DCU) and Prof. Meenal Datta (University of Notre Dame) have been awarded one of the 2026 Notre Dame-DCU Exchange Grants in Precision Biomedical Technologies.

We are pleased to announce that our perspective paper, “Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation,” has been recognised as one of the top-cited articles of 2024–2025 in the Beilstein Journal of Nanotechnology.

ALERT consortium is moving fast towards it aim with a renewed optimism and spirit! The first technical meeting has concluded and the scenario is clear: the development of multi-analyte devise for minimally invasive Alzheimer’s disease diagnosis is a complex and ambitus task.

Prof. Silvia Giordani was invited as a lecturer at the third edition of the Nanochemistry Camp, an international summer school for Master’s and PhD students in Chemistry and Physics from around the world.

We are thrilled to announce our participation in BIO-NANOAGE, a newly funded 12-month ECIU Research Seed Project entitled “Modern Cosmeceutical: Traditional Plant Extracts vs Nanoparticle Products as Potential Anti-Aging Factors,” this project officially kicked off with an in-person meeting in Łódź, Poland.

We are delighted to share that Prof. Silvia Giordani has been appointed to the Governing Board of the European Materials Research Society (E-MRS). This is a great honour and an exciting opportunity to contribute to the activities and future development of the European materials research community.

We are pleased to announce a new thematic issue of the Beilstein Journal of Nanotechnology, Functional Materials at the Biointerface, co-edited by Prof. Silvia Giordani (Dublin City University), Dr. Francesco Calzaferri (Institut des Biomolecules Max Mousseron, Montpellier), and Dr.